fbpx
November 16, 2020

EMA Panel Backs Xofluza for Influenza, Post-Exposure Prophylaxis EMA Panel Backs Xofluza for Influenza, Post-Exposure Prophylaxis

At its November meeting, the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the antiviral baloxavir marboxil (Xofluza, Roche) for treatment and post-exposure […]
November 16, 2020

Moderna: Interim Data Show 94.5% Efficacy for Its COVID-19 Vaccine Moderna: Interim Data Show 94.5% Efficacy for Its COVID-19 Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Moderna mRNA-1273 vaccine, in development to prevent COVID-19, yielded 94.5% efficacy […]
November 6, 2020

FDA Broadens Ticagrelor Indication to Stroke Prevention FDA Broadens Ticagrelor Indication to Stroke Prevention

The US Food and Drug Administration (FDA) has approved the antiplatelet agent ticagrelor (Brilinta) to reduce the risk for stroke in patients with acute ischemic stroke […]
November 4, 2020

Medtronic Recalls Rashkind Balloon Septostomy Catheters Medtronic Recalls Rashkind Balloon Septostomy Catheters

Medtronic is recalling Rashkind balloon septostomy catheters because of quality problems that may lead to the device breaking, separating, or failing during use, which could cause […]
November 4, 2020

FDA Okays Ranger Drug-Coated Balloon for PAD FDA Okays Ranger Drug-Coated Balloon for PAD

The US Food and Drug Administration (FDA) has approved Boston Scientific’s Ranger drug-coated balloon (DCB) for the treatment of peripheral artery disease, the company announced Monday. […]
October 27, 2020

Security Breach Leads to Psychiatric Patient Blackmail Security Breach Leads to Psychiatric Patient Blackmail

Hackers have accessed patient records at Finland’s largest private psychotherapy system, emailing some patients to pay up or face having their private medical records released online. […]
October 19, 2020

EMA Panel Backs Peanut Allergy Desensitizing Powder Palforzia EMA Panel Backs Peanut Allergy Desensitizing Powder Palforzia

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) recommended on October 15 that marketing authorization be granted for Palforzia (Aimmune Therapeutics). […]
October 19, 2020

EMA Recommends First Long-Acting Injectable HIV Treatment EMA Recommends First Long-Acting Injectable HIV Treatment

The first long-acting injectable treatments for HIV were recommended for marketing approval on October 16 by the European Medicines Agency (EMA). A combination injection of two […]
October 16, 2020

EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma

The European Medicines Agency (EMA) today recommended granting conditional marketing authorization to brexucabtagene autoleucel (Tecartus), making it the first approved chimeric antigen receptor (CAR) T-cell therapy for the […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0